PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
4 hedge funds and large institutions have $1.86M invested in PureTech Health in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
23% less capital invested
Capital invested by funds: $2.4M → $1.86M (-$540K)
Top Buyers
| 1 |
Jane Street
New York
|
+$16.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$215 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$54 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $1.61M | – | – | – |
|
|
2
Jane Street
New York
| $247K | +$16.3K | +608 | +6% |
|
|
3
UBS Group
Zurich,
Switzerland
| $644 | +$215 | +8 | +40% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $46 | +$54 | +2 | New |
|
PRTC Hedge Fund Activity: Q3 2023 in Review
4 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q3 2023, worth a combined $1.86M — down 23% from $2.4M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PRTC positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, adding an estimated $16.3K.
- 4 institutional investors held PureTech Health (PRTC) as of Q3 2023, up from 3 in Q2 2023.
- Funds reported $1.86M of PureTech Health stock for Q3 2023, down 23% quarter-over-quarter.
- 1 fund opened new PureTech Health positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest PureTech Health buyer in Q3 2023 was Jane Street, an estimated $16.3K added.
Based on aggregated 13F filings for Q3 2023.